This topic contains a solution. Click here to go to the answer

Author Question: A patient who frequently takes diphenhydramine (Benadryl) to prevent motion sickness is scheduled ... (Read 29 times)

vicotolentino

  • Hero Member
  • *****
  • Posts: 552
A patient who frequently takes diphenhydramine (Benadryl) to prevent motion sickness is scheduled for skin testing to diagnose possible allergies. For what number of days should the pa-tient refrain from taking diphenhydramine before skin testing?
 
  a. 1
  b. 2
  c. 4
  d. 7

Question 2

A patient is receiving hydroxyzine (Vistaril) for complaints of nausea and vomiting. Consider the following adverse effects of the drug, and select the one that is most significant.
 
  a. Excessive salivation
  b. Increased pulse
  c. Decreased respiratory rate
  d. Sedation



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Joc

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

ANS: C
Allergy skin testing may be falsely negative in patients taking dimenhydrinate, diphenhydramine, and meclizine at the time of testing. Discontinue diphenhydramine 4 days before testing.

Answer to Question 2

ANS: D
Hydroxyzine is an antihistamine that is also an anticholinergic because it blocks the action of ac-etylcholine in the brain. As such, it causes sedation as the most significant adverse effect.





 

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

For a complete list of videos, visit our video library